Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Analysis of the Duration of Combination Therapy That is Necessary for HCV Genotype 1 Eradication
This study has been completed.
Study NCT00152581 Information provided by University College London Hospitals
First Received: September 7, 2005 Last Updated: November 29, 2005
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Chronic Hepatitis C, HCV Genotype 1
Additional conditions recognized in this trial
Hepatitis
Hepatitis C
Hepatitis C, Chronic
Hepatitis, Chronic
More general conditions related to this trial
Digestive System Diseases
Flaviviridae Infections
Hepatitis, Viral, Human
Liver Diseases
RNA Virus Infections
Virus Diseases
Additional drug interventions recognized in this trial
Interferon Alfa-2a
Interferon-alpha
Peginterferon alfa-2a
More general drug interventions related to this trial
Angiogenesis Inhibitors
Angiogenesis Modulating Agents
Anti-Infective Agents
Antineoplastic Agents
Antiviral Agents
Growth Inhibitors
Growth Substances
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
University College London Hospitals
Back to top of Main Content
